Liver biopsy: complications in 1000 inpatients and outpatients

Gastroenterology
|January 1, 1978
PubMed

Insights

Outpatient liver biopsy is safe for most patients when a 3-hour observation period and hospital support are available. Approximately 5% of patients may require hospitalization after the procedure.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Medical Procedures

Background:

  • Liver biopsy is a common diagnostic procedure.
  • Patient selection and procedural safety are critical considerations.

Purpose of the Study:

  • To prospectively evaluate risk factors and safety of liver biopsy in an outpatient setting.
  • To compare outcomes between outpatient and inpatient liver biopsies.

Main Methods:

  • Prospective evaluation of 1000 consecutive patients undergoing liver biopsy.
  • Data collection on patient demographics, diagnoses, contraindications, and complications.
  • Comparison of outcomes between outpatient and inpatient groups.

Main Results:

  • No deaths or laparotomies occurred in 1000 patients.
  • 5.9% experienced moderate to severe pain or hypotension, manifesting within 3 hours post-biopsy.
  • 5.3% of outpatients required hospitalization, with most discharged within 36 hours.
  • Complications were associated with relative contraindications and increased needle passes.
  • Hepatitis-cirrhosis patients had higher complication rates (12.8%) compared to other diagnoses.

Conclusions:

  • Outpatient liver biopsy is safe with adequate observation and hospital support.
  • Careful patient selection and monitoring are essential for minimizing complications.
  • Specific patient groups, like those with hepatitis-cirrhosis, may require closer attention.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...